Philips recalled millions of CPAP and BiPAP devices in 2021 after their sound-dampening foam was found to degrade — potentially releasing particles and chemicals users inhaled nightly for years.
Philips Respironics' DreamStation, SystemOne, and related CPAP/BiPAP devices used polyester-based polyurethane (PE-PUR) foam to dampen sound and vibration. The foam was found to degrade — potentially releasing particles and chemical gases directly into the device's air pathway.
In June 2021, Philips recalled millions of devices worldwide. Users had inhaled air passing over degrading foam nightly — in many cases for years — and reported respiratory problems, headaches, cancers, and organ conditions allegedly connected to exposure.
Federal claims are consolidated in MDL 3014 in the Western District of Pennsylvania. Philips agreed to a ~$1.1 billion personal-injury settlement program in 2024 alongside earlier economic-loss settlements — registration deadlines have closed for some tracks, but claim evaluation continues for eligible users.
Philips agreed to a ~$1.1 billion personal-injury settlement program in 2024 — registration deadlines for some tracks have closed, but claim evaluation continues. MDL 3014 proceedings are in the settlement-administration phase.
Qualification criteria change as litigation develops. The only way to know whether your experience may fit the current criteria is a review.
The Philips CPAP campaign is pre-selected below. Tell us what happened — a specialist will review whether your information may fit the current criteria.
You are reviewing: Philips CPAP Claims. Complete the form — a case specialist may follow up if your information appears to fit.
Attorney advertising. The Torts Attorney provides legal marketing and case-acquisition services and is not a law firm. Submitting this form does not create an attorney-client relationship and does not guarantee review, acceptance, or any outcome. Prior results do not guarantee similar outcomes.